International Clinical Trial: A Machine Learning-Based Risk Prediction Model for Immune-Related Cutaneous Adverse Events

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125124) titled 'A Machine Learning-Based Risk Prediction Model for Immune-Related Cutaneous Adverse Events' on May 21.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Zhongshan Hospital, Fudan University

Condition: Cutaneous immune-related adverse event

Intervention: Training Set:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Training Set:10500;Test Set:4500;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=317147

Disclaimer: Curated by HT Syndication....